132 related articles for article (PubMed ID: 29058054)
1. Long-Term High-Dose Resveratrol Supplementation Reduces Bone Mass and Fracture Strength in Rats.
Ornstrup MJ; Brüel A; Thomsen JS; Harsløf T; Langdahl BL; Pedersen SB
Calcif Tissue Int; 2018 Mar; 102(3):337-347. PubMed ID: 29058054
[TBL] [Abstract][Full Text] [Related]
2. Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: densitometric, histomorphometric and microtomographic studies.
Libouban H; Blouin S; Moreau MF; Baslé MF; Audran M; Chappard D
Micron; 2008 Oct; 39(7):998-1007. PubMed ID: 18023586
[TBL] [Abstract][Full Text] [Related]
3. PTH (1-34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats.
Brent MB; Brüel A; Thomsen JS
Bone; 2018 May; 110():244-253. PubMed ID: 29475111
[TBL] [Abstract][Full Text] [Related]
4. Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats.
Vegger JB; Nielsen ES; Brüel A; Thomsen JS
Bone; 2014 Sep; 66():287-95. PubMed ID: 24970039
[TBL] [Abstract][Full Text] [Related]
5. The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar.
Brent MB; Thomsen JS; Brüel A
Front Endocrinol (Lausanne); 2020; 11():588773. PubMed ID: 33162940
[TBL] [Abstract][Full Text] [Related]
6. Disuse-induced loss of bone mineral density and bone strength is attenuated by post-lactational bone gain in NMRI mice.
Sørensen TG; Brent MB; Thomsen JS; Brüel A
Bone; 2020 Feb; 131():115183. PubMed ID: 31794846
[TBL] [Abstract][Full Text] [Related]
7. Vertical Trabeculae are Thinned More Than Horizontal Trabeculae in Skeletal-Unloaded Rats.
Vegger JB; Brüel A; Thomsen JS
Calcif Tissue Int; 2015 Nov; 97(5):516-26. PubMed ID: 26163234
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone mitigates loss of periosteal bone formation and muscle mass in disuse osteopenic rats.
Grubbe MC; Thomsen JS; Nyengaard JR; Duruox M; Brüel A
J Musculoskelet Neuronal Interact; 2014 Dec; 14(4):473-83. PubMed ID: 25524973
[TBL] [Abstract][Full Text] [Related]
9. Pantoprazole, a proton pump inhibitor, does not prevent botulinum toxin induced disuse osteopenia in mice.
Vegger JB; Brüel A; Thomsen JS
J Musculoskelet Neuronal Interact; 2017 Sep; 17(3):162-175. PubMed ID: 28860418
[TBL] [Abstract][Full Text] [Related]
10. PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats.
Brüel A; Vegger JB; Raffalt AC; Andersen JE; Thomsen JS
Bone; 2013 Mar; 53(1):51-8. PubMed ID: 23246791
[TBL] [Abstract][Full Text] [Related]
11. Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats.
Mosekilde L; Thomsen JS; Mackey MS; Phipps RJ
Bone; 2000 Nov; 27(5):639-45. PubMed ID: 11062350
[TBL] [Abstract][Full Text] [Related]
12. Effects of alendronate and strontium ranelate on cancellous and cortical bone mass in glucocorticoid-treated adult rats.
Sun P; Cai DH; Li QN; Chen H; Deng WM; He L; Yang L
Calcif Tissue Int; 2010 Jun; 86(6):495-501. PubMed ID: 20390406
[TBL] [Abstract][Full Text] [Related]
13. Loss of bone strength is dependent on skeletal site in disuse osteoporosis in rats.
Thomsen JS; Christensen LL; Vegger JB; Nyengaard JR; Brüel A
Calcif Tissue Int; 2012 Apr; 90(4):294-306. PubMed ID: 22354132
[TBL] [Abstract][Full Text] [Related]
14. Dynamic acoustic radiation force retains bone structural and mechanical integrity in a functional disuse osteopenia model.
Uddin SM; Qin YX
Bone; 2015 Jun; 75():8-17. PubMed ID: 25661670
[TBL] [Abstract][Full Text] [Related]
15. [Resveratrol and puerarin on peak bone mass in young rats].
Xi HR; Yang FF; Gao YH; Ma HP; Chen KM
Zhongguo Gu Shang; 2018 Jul; 31(7):635-641. PubMed ID: 30103587
[TBL] [Abstract][Full Text] [Related]
16. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol supplementation preserves long bone mass, microstructure, and strength in hindlimb-suspended old male rats.
Durbin SM; Jackson JR; Ryan MJ; Gigliotti JC; Alway SE; Tou JC
J Bone Miner Metab; 2014 Jan; 32(1):38-47. PubMed ID: 23686002
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol supplementation influences bone properties in the tibia of hindlimb-suspended mature Fisher 344 × Brown Norway male rats.
Durbin SM; Jackson JR; Ryan MJ; Gigliotti JC; Alway SE; Tou JC
Appl Physiol Nutr Metab; 2012 Dec; 37(6):1179-88. PubMed ID: 23050779
[TBL] [Abstract][Full Text] [Related]
19. Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice.
Funck-Brentano T; Nilsson KH; Brommage R; Henning P; Lerner UH; Koskela A; Tuukkanen J; Cohen-Solal M; Movérare-Skrtic S; Ohlsson C
J Endocrinol; 2018 Jul; 238(1):13-23. PubMed ID: 29720540
[TBL] [Abstract][Full Text] [Related]
20. Muscle and bone follow similar temporal patterns of recovery from muscle-induced disuse due to botulinum toxin injection.
Manske SL; Boyd SK; Zernicke RF
Bone; 2010 Jan; 46(1):24-31. PubMed ID: 19853070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
